双相障碍罕见致病/可能致病变异的编码区变异研究
该研究基于双相测序联盟四个队列,分析3,987例双相障碍患者与5,322名对照的外显子序列,评估罕见致病/可能致病单核苷酸变异负荷。结果发现,在双相障碍GWAS区域基因中P-LP变异负荷增加(OR=1.9,95%CI=1.3-2.8,单侧p=6.0×10-4),但在独立样本9,929例患者与14,018名对照中未重复(OR=0.9,单侧p=0.70);全外显子及多组生物学候选基因中均未见可重复富集。
要点
- 双相障碍患者在全外显子水平未显示罕见P-LP变异的可重复富集。
- 双相障碍GWAS区域基因中P-LP变异负荷增加仅见于初始样本,未在独立样本重复。
- 双相障碍与精神分裂症共享常见变异易感性,但罕见P-LP编码变异未见关联。
核心结论
- 双相障碍个体不携带全外显子或生物学候选基因中罕见P-LP变异的可重复富集。
- 尽管双相障碍与精神分裂症共享常见变异易感性,但未观察到双相障碍风险与精神分裂症相关基因中罕见P-LP编码变异关联。
研究设计与样本
- 研究纳入双相测序联盟四个队列的3,987例无亲缘关系双相障碍患者和5,322名对照,以欧洲 ancestry 为主。
- 评估罕见、影响蛋白的单核苷酸变异(归类为致病或可能致病,P-LP)在全外显子及多组候选基因中的负荷。
- 重复分析纳入另外9,929例双相障碍患者和14,018名对照。
主要发现
- 在165个双相障碍GWAS区域基因中,3,987例患者P-LP变异负荷增加(meta分析OR=1.9,95%CI=1.3-2.8,单侧p=6.0×10-4)。
- 该富集在9,929例患者和14,018名对照中未重复(OR=0.9,单侧p=0.70)。
- 在精神分裂症GWAS基因、两类神经元突触基因(RBFOX2和FMRP)及功能缺失不耐受基因中,未观察到P-LP变异显著富集。
关键数值与推荐
- 双相障碍GWAS区域165个基因中P-LP变异负荷:OR=1.9,95%CI=1.3-2.8,单侧p=6.0×10-4(初始样本)。
- 重复样本中同一分析:OR=0.9,单侧p=0.70。
临床怎么用
- 当前证据不支持将罕见P-LP编码变异作为双相障碍的常规遗传风险评估或诊断依据。
- 临床解读双相障碍遗传检测结果时,应谨慎对待基于小样本候选基因富集的发现。
局限性
- 初始样本中双相障碍GWAS区域基因的P-LP变异富集未在独立样本重复。
- 研究以外显子序列为主,未覆盖非编码变异。
- 样本以欧洲 ancestry 为主,推广至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bipolar disorder (BD) is a serious mental illness with substantial common variant heritability. However, the role of rare coding variation in BD is not well established. We examined the protein-coding (exonic) sequences of 3,987 unrelated individuals with BD and 5,322 controls of predominantly European ancestry across four cohorts from the Bipolar Sequencing Consortium (BSC). We assessed the burden of rare, protein-altering, single nucleotide variants classified as pathogenic or likely pathogenic (P-LP) both exome-wide and within several groups of genes with phenotypic or biologic plausibility in BD. While we observed an increased burden of rare coding P-LP variants within 165 genes identified as BD GWAS regions in 3,987 BD cases (meta-analysis OR = 1.9, 95% CI = 1.3-2.8, one-sided p = 6.0 × 10-4), this enrichment did not replicate in an additional 9,929 BD cases and 14,018 controls (OR = 0.9, one-side p = 0.70). Although BD shares common variant heritability with schizophrenia, in the BSC sample we did not observe a significant enrichment of P-LP variants in SCZ GWAS genes, in two classes of neuronal synaptic genes (RBFOX2 and FMRP) associated with SCZ or in loss-of-function intolerant genes. In this study, the largest analysis of exonic variation in BD, individuals with BD do not carry a replicable enrichment of rare P-LP variants across the exome or in any of several groups of genes with biologic plausibility. Moreover, despite a strong shared susceptibility between BD and SCZ through common genetic variation, we do not observe an association between BD risk and rare P-LP coding variants in genes known to modulate risk for SCZ.
引用
- Jia X, Goes FS, Locke AE, et al. Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder. Mol Psychiatry. 2021. PMID: 33483695. doi:10.1038/s41380-020-01006-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。